All Stories

  1. Revolution in the Synthesis, Physio-chemical and Biological Characterization of Gold Nanoplatform

    Article • Current Pharmaceutical Design, August 2021, Bentham Science Publishers

    Tan Kin Fai, Dr Vijayaraj kumar Palanirajan

  2. Rabbit as an Animal Model for Pharmacokinetics Studies of Enteric Capsule Contains Recombinant Human Keratinocyte Growth Factor Loaded Chitosan Nanoparticles

    Article • Current Clinical Pharmacology, October 2019, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  3. Detection of Formation of Recombinant Human Keratinocyte Growth Factor Loaded Chitosan Nanoparticles Based on its Optical Properties

    Article • Current Nanoscience, February 2018, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  4. Tuberculosis Drug delivery System

    Article • Current Drug Therapy, September 2017, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  5. Optimization and In-vitro Evaluation of Coating Process for Film-Coated Tablets

    Article • International Journal of Food Engineering, January 2017, De Gruyter

    Dr Vijayaraj kumar Palanirajan

  6. Antiepileptic properties of novel 2-(substituted benzylidene)-7-(4-chlorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one derivatives

    Article • Journal of Saudi Chemical Society, September 2016, Elsevier

    Dr Vijayaraj kumar Palanirajan

  7. Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel

    Article • International Journal of Pharmaceutical Investigation, January 2016, Medknow

    Dr Vijayaraj kumar Palanirajan

  8. Enhanced Cytotoxic Effect of Chemically Conjugated Polymeric Sirolimus against HT-29 Colon Cancer and A-549 Lung Cancer Cell Lines

    Article • Journal of Pharmaceutics & Drug Delivery Research, January 2015, OMICS Publishing Group

    Dr Vijayaraj kumar Palanirajan

  9. Microwave-assisted synthesis, characterization and biological activity of novel pyrazole derivatives

    Article • Journal of Saudi Chemical Society, December 2014, Elsevier

    Dr Vijayaraj kumar Palanirajan

  10. Designing and In-Vitro Characterization of Micelle Forming Amphiphilic PEGylated Rapamycin Nanocarriers for the Treatment of Gastric Cancer

    Article • Current Drug Delivery, September 2014, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  11. Antiepileptic Activity of Novel 2-(substituted benzylidene)-7-(4- fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one Derivatives

    Article • Letters in Drug Design & Discovery, March 2013, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  12. Antiepileptic Activity of Novel 2-(substituted benzylidene)-7-(4- fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one Derivatives

    Article • Letters in Drug Design & Discovery, January 2013, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  13. PEGylated dendritic nanoarchitechture improves mean survival time of BDF1 mice bearing myelogenous k -562 leukemia

    Article • Journal of Acute Disease, January 2013, Asian Pacific Journal of Tropical Medicine Press

    Dr Vijayaraj kumar Palanirajan

  14. RP-HPLC determination of vildagliptin in pure and in tablet formulation

    Article • Journal of Pharmacy Research, January 2013, Elsevier

    Dr Vijayaraj kumar Palanirajan

  15. RP-HPLC method for the determination of acipimox in human plasma

    Article • Journal of Pharmacy Research, January 2013, Elsevier

    Dr Vijayaraj kumar Palanirajan

  16. Design, synthesis, antinociceptive, and anti-inflammatory properties of thiazolopyrimidine derivatives

    Article • Toxicological and Environmental Chemistry, August 2012, Taylor & Francis

    Dr Vijayaraj kumar Palanirajan

  17. Efavirenz Loaded Novel Citric Acid Dendritic Architecture for Increased Solubility and Sustained Delivery

    Article • Journal of Pharmaceutics & Drug Delivery Research, January 2012, OMICS Publishing Group

    Dr Vijayaraj kumar Palanirajan

  18. Synthesis, characterization, and antihyperglycemic activity of novel oxazolidine derivatives

    Article • Archives of Pharmacal Research, June 2011, Springer Science + Business Media

    Dr Vijayaraj kumar Palanirajan

  19. Synthesis and anticonvulsant activity of 6,7,8,9-tetra hydro-5H-5-(2′-hydroxy phenyl)-2-(4′-substituted benzylidine)-3-(4-nitrophenyl amino) thiazolo quinazoline derivatives

    Article • Toxicological and Environmental Chemistry, April 2011, Taylor & Francis

    Dr Vijayaraj kumar Palanirajan

  20. ChemInform Abstract: Synthesis of Novel 6,7,8,9-Tetrahydro-5H-5-hydroxyphenyl-2-benzylidene-3-substituted Hydrazino Thiazolo(2,3-b)quinazoline as Potent Antinociceptive and Antiinflammatory Agents.

    Article • ChemInform, March 2011, Wiley

    Dr Vijayaraj kumar Palanirajan

  21. Synthesis of Novel 6,7,8,9-Tetrahydro-5H-5-hydroxyphenyl-2-benzylidine-3-substituted Hydrazino Thiazolo (2,3-b) Quinazoline as Potent Antinociceptive and Anti-inflammatory Agents

    Article • Bulletin of the Korean Chemical Society, November 2010, Korean Chemical Society

    Dr Vijayaraj kumar Palanirajan

  22. Dendrimers in Oncology: An Expanding Horizon

    Article • Chemical Reviews, April 2010, American Chemical Society (ACS)

    Dr Vijayaraj kumar Palanirajan

  23. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist

    Article • European Journal of Medicinal Chemistry, March 2009, Elsevier

    Dr Vijayaraj kumar Palanirajan

  24. UV Spectrophotometric Estimation of Acipimox inBulk and Capsule Dosage Form

    Article • E-Journal of Chemistry, January 2009, Hindawi Publishing Corporation

    Dr Vijayaraj kumar Palanirajan

  25. UV Spectrophotometric Method for Determination of Cinitapride in Pure and its Solid Dosage Form

    Article • E-Journal of Chemistry, January 2009, Hindawi Publishing Corporation

    Dr Vijayaraj kumar Palanirajan

  26. Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles

    Article • AAPS PharmSciTech, March 2007, American Association of Pharmaceutical Scientists (AAPS)

    Dr Vijayaraj kumar Palanirajan

  27. Pharmaceutical and Biomedical Potential of PEGylated Dendrimers

    Article • Current Pharmaceutical Design, February 2007, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  28. PEGylated Dendritic Architecture for Development of a Prolonged Drug Delivery System for an Antitubercular Drug

    Article • Current Drug Delivery, January 2007, Bentham Science Publishers

    Dr Vijayaraj kumar Palanirajan

  29. Dendrosome-based gene delivery

    Article • Journal of Experimental Nanoscience, June 2006, Taylor & Francis

    Dr Vijayaraj kumar Palanirajan

  30. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers

    Article • Journal of Drug Targeting, January 2006, Taylor & Francis

    Dr Vijayaraj kumar Palanirajan

  31. Functional Polymeric Nanoparticles: An Efficient and Promising Tool for Active Delivery of Bioactives

    Article • Critical Reviews in Therapeutic Drug Carrier Systems, January 2006, Begell House

    Dr Vijayaraj kumar Palanirajan

  32. Evaluation of Antidiarrheal Potential of Emblica officinalis.

    Article • Pharmaceutical Biology, January 2005, Taylor & Francis

    Dr Vijayaraj kumar Palanirajan